A recent study published in the journal Microbiome has uncovered an interesting discovery in NASA’s cleanrooms: new species ...

The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 vector technology.

Grit Biotechnology Co., Ltd. ('Grit Bio'), a clinical-stage biotech pioneering novel immunotherapies announced today that three research programs, in collaboration with Vitalgen BioPharma Co., Ltd.

Some of these new regulations have been more successful ... would need to be very diligently substantiated. HB: What advances in biotech regulations do you expect we will see over the next 10 ...

Natural products are among the most promising candidates for the development of new drugs. However, due to their structural complexity, they are often difficult to access.

Princeton Engineering Innovation Research Grants support bold new ideas tackling critical problems like antibiotic resistance ...

April 14, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC ... its public reporting obligations with the filing of its most recent quarterly report on Form 10-Q on March 4, 2025; and intends ...

Bioheaven360 introduces AI-driven genomics diagnostic platform for early disease detection: Our Bureau, Bengaluru Thursday, May 8, 2025, 14:15 Hrs [IST] Bioheaven360 Genotec, a le ...

In little over three decades, advances in biotechnology have noticeably disrupted ... Amid increasing demand for new biologics, the pharma industry is shifting focus from exploring potential ...

As the largest funder of biomedical research in the world, the NIH is considered a global paragon. Budget cuts could lead to ...

The traditional 60-40 stock and bond portfolio for retirement financial security is dead, says Ric Edelman, but the reason is ...